Bio-Rad Laboratories (BIO-B) Operating Expenses (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Operating Expenses data on file, last reported at $275.3 million in Q1 2026.

• Quarterly Operating Expenses fell 2.48% year-over-year to $275.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (changed 0.18% YoY) and the FY2025 annual result came in at $1.1 billion, up 0.9% from the prior year.
• Operating Expenses fell to $275.3 million in Q1 2026 per BIO-B's latest filing, from $291.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $300.5 million in Q1 2023 and bottomed at $244.7 million in Q3 2023.
• The 5-year median for Operating Expenses is $277.9 million (2022), against an average of $275.2 million.
• The widest annual swing landed in 2022, when Operating Expenses slipped 14.52%; it then grew 19.07% in 2024.
• Tracing BIO-B's Operating Expenses over 5 years: stood at $278.4 million in 2022, then retreated by 2.66% to $271.0 million in 2023, then rose by 4.65% to $283.6 million in 2024, then rose by 2.72% to $291.3 million in 2025, then fell by 5.49% to $275.3 million in 2026.
• Per Business Quant, the three latest BIO-B Operating Expenses figures stand at $275.3 million (Q1 2026), $291.3 million (Q4 2025), and $278.1 million (Q3 2025).

Peer Comparison